UA116517C2 - Фармацевтична композиція для лікування захворювань шлунково-кишкового тракту - Google Patents

Фармацевтична композиція для лікування захворювань шлунково-кишкового тракту

Info

Publication number: UA116517C2
Authority: UA; Ukraine
Prior art keywords: pharmaceutical composition; diseases; treatment; sucralfate; ranitidine
Prior art date: 2015-01-30

Application number

UAA201707833A

Other languages

English (en)

Ukrainian (uk)

Inventor

Йон Хо Джо

Джун Воо Лее

Original Assignee

Девон Фармасьютікал Ко., Лтд.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-01-30

Filing date

2016-01-28

Publication date

2018-03-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55169799&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA116517(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-01-28 Application filed by Девон Фармасьютікал Ко., Лтд. filed Critical Девон Фармасьютікал Ко., Лтд.

2018-03-26 Publication of UA116517C2 publication Critical patent/UA116517C2/uk

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
210000001035 gastrointestinal tract Anatomy 0.000 title 1
229960004645 bismuth subcitrate Drugs 0.000 abstract 3
ZQUAVILLCXTKTF-UHFFFAOYSA-H bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [K+].[K+].[K+].[Bi+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZQUAVILLCXTKTF-UHFFFAOYSA-H 0.000 abstract 3
VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 abstract 3
229960000620 ranitidine Drugs 0.000 abstract 3
229960004291 sucralfate Drugs 0.000 abstract 3
MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 abstract 3
208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
229940000425 combination drug Drugs 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

UAA201707833A 2015-01-30 2016-01-28 Фармацевтична композиція для лікування захворювань шлунково-кишкового тракту UA116517C2 (uk)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR20150015339		2015-01-30
KR1020150147513A KR101583452B1 (ko)	2015-01-30	2015-10-22	위장질환 치료용 의약 조성물
PCT/KR2016/000935 WO2016122226A2 (fr)	2015-01-30	2016-01-28	Composition pharmaceutique pour le traitement de maladies gastro-intestinales

Publications (1)

Publication Number	Publication Date
UA116517C2 true UA116517C2 (uk)	2018-03-26

Family

ID=55169799

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA201707833A UA116517C2 (uk)	2015-01-30	2016-01-28	Фармацевтична композиція для лікування захворювань шлунково-кишкового тракту

Country Status (19)

Country	Link
EP (1)	EP3250199A4 (fr)
JP (1)	JP6419347B2 (fr)
KR (2)	KR101583452B1 (fr)
CN (1)	CN107205947B (fr)
AR (1)	AR105413A1 (fr)
CL (1)	CL2017001680A1 (fr)
CO (1)	CO2017006222A2 (fr)
EA (1)	EA032385B9 (fr)
EC (1)	ECSP17038599A (fr)
GE (2)	GEP20186941B (fr)
MA (1)	MA41432A (fr)
MX (1)	MX375765B (fr)
MY (1)	MY195824A (fr)
PE (1)	PE20171340A1 (fr)
PH (1)	PH12017550051A1 (fr)
SA (1)	SA517382016B1 (fr)
TW (1)	TWI635859B (fr)
UA (1)	UA116517C2 (fr)
WO (1)	WO2016122226A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101988479B1 (ko)	2017-10-11	2019-09-24	(주)휴럼	리트세노라이드를 유효성분으로 하는 헬리코박터 파이로리 균주로부터 유래되는 위장질환 예방 및 치료용 약학 조성물
WO2019199134A1 (fr) *	2018-04-13	2019-10-17	주식회사 삼양바이오팜	Composition pharmaceutique comprenant du lénalidomide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0282132B1 (fr) *	1987-03-09	1992-09-30	The Procter & Gamble Company	Compositions et leur utilisation dans le traitement d'affections gastrointestinales
US4990610A (en) *	1988-08-25	1991-02-05	Applied Analytical Industries, Inc.	Method for preparing high potency sucralfate
EP0403048A3 (fr) *	1989-06-14	1991-01-30	Warner-Lambert Company	Un modèle de structure de système craniomandibulaire humain
KR970006083B1 (ko) *	1992-01-22	1997-04-23	주식회사 대웅제약	위장질환 치료용 의약 조성물
ATE213635T1 (de) *	1994-04-26	2002-03-15	Chugai Pharmaceutical Co Ltd	Verfahren für die herstellung schmelz-granulierte sucralfatzubereitung
JPH0879097A (ja) *	1994-09-01	1996-03-22	Matsushita Electric Ind Co Ltd	携帯無線機
KR970006083A (ko)	1995-07-06	1997-02-19	한승준	자동차용 카울부의 와이어 고정장치 취부구조
JP2001513570A (ja) *	1997-08-25	2001-09-04	ザ、プロクター、エンド、ギャンブル、カンパニー	上部胃腸管不調治療用複合製剤
AU4655199A (en)	1999-06-21	2001-01-09	Dae Woong Pharmaceutical Co., Ltd.	Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate
JP2006076956A (ja) *	2004-09-10	2006-03-23	Taiyo Yakuhin Kogyo Kk	胃炎の治療・予防用配合剤
KR101617054B1 (ko) *	2008-07-01	2016-04-29	라이온 가부시키가이샤	고형내복제제
KR20110105223A (ko) *	2010-03-18	2011-09-26	일양약품주식회사	일라프라졸 및 수크랄페이트와 비스무스 제제의 혼합물을 함유하는 위장질환을 예방 또는 치료하기 위한 경구용 약제 조성물
KR20140072673A (ko)	2012-12-05	2014-06-13	(주)한국파비스제약	경구용 위장질환 치료를 위한 정제

2015
- 2015-10-22 KR KR1020150147513A patent/KR101583452B1/ko active Active
- 2015-12-31 KR KR1020150190850A patent/KR20160094268A/ko not_active Withdrawn
2016
- 2016-01-27 MA MA041432A patent/MA41432A/fr unknown
- 2016-01-27 TW TW105102582A patent/TWI635859B/zh active
- 2016-01-28 PE PE2017001147A patent/PE20171340A1/es unknown
- 2016-01-28 CN CN201680007680.7A patent/CN107205947B/zh active Active
- 2016-01-28 UA UAA201707833A patent/UA116517C2/uk unknown
- 2016-01-28 GE GEAP201814551A patent/GEP20186941B/en unknown
- 2016-01-28 JP JP2017540683A patent/JP6419347B2/ja active Active
- 2016-01-28 WO PCT/KR2016/000935 patent/WO2016122226A2/fr not_active Ceased
- 2016-01-28 GE GEAP201614551A patent/GEP20196941B/en unknown
- 2016-01-28 MX MX2017007567A patent/MX375765B/es active IP Right Grant
- 2016-01-28 EP EP16743704.5A patent/EP3250199A4/fr not_active Withdrawn
- 2016-01-28 MY MYPI2017702737A patent/MY195824A/en unknown
- 2016-01-28 EA EA201791458A patent/EA032385B9/ru not_active IP Right Cessation
- 2016-01-29 AR ARP160100272A patent/AR105413A1/es not_active Application Discontinuation
2017
- 2017-06-20 EC ECIEPI201738599A patent/ECSP17038599A/es unknown
- 2017-06-23 CO CONC2017/0006222A patent/CO2017006222A2/es unknown
- 2017-06-23 CL CL2017001680A patent/CL2017001680A1/es unknown
- 2017-07-25 PH PH12017550051A patent/PH12017550051A1/en unknown
- 2017-07-29 SA SA517382016A patent/SA517382016B1/ar unknown

Also Published As

Publication number	Publication date
MY195824A (en)	2023-02-22
KR101583452B1 (ko)	2016-01-11
CO2017006222A2 (es)	2017-09-20
BR112017013857A2 (pt)	2018-02-27
AR105413A1 (es)	2017-10-04
MA41432A (fr)	2017-12-05
WO2016122226A3 (fr)	2016-09-15
PH12017550051A1 (en)	2018-01-29
JP2018503672A (ja)	2018-02-08
ECSP17038599A (es)	2017-09-29
EA032385B1 (ru)	2019-05-31
KR101583452B9 (ko)	2022-05-02
GEP20186941B (en)	2019-01-10
GEP20196941B (en)	2019-01-10
PE20171340A1 (es)	2017-09-13
WO2016122226A2 (fr)	2016-08-04
EA201791458A1 (ru)	2017-11-30
EP3250199A2 (fr)	2017-12-06
TWI635859B (zh)	2018-09-21
CL2017001680A1 (es)	2018-01-12
TW201639559A (zh)	2016-11-16
CN107205947A (zh)	2017-09-26
GEAP201814551A (en)	2018-08-27
CN107205947B (zh)	2020-05-22
EP3250199A4 (fr)	2018-08-08
MX375765B (es)	2025-03-07
JP6419347B2 (ja)	2018-11-07
SA517382016B1 (ar)	2021-03-18
EA032385B9 (ru)	2019-07-31
MX2017007567A (es)	2017-10-19
KR20160094268A (ko)	2016-08-09

Similar Documents

Publication	Publication Date	Title
PH12018502747A1 (en)	2019-12-11	Boronic acid derivatives and therapeutic uses thereof
NZ780890A (en)	2024-11-29	Pharmaceutical compositions comprising meloxicam
JOP20170135A1 (ar)	2017-11-30	مركبات ديازاسبيروألكيل مثيل-إندول
EA201892395A1 (ru)	2019-04-30	Лекарственные составы ингибитора lsd1
PH12020550341A1 (en)	2021-02-15	Niraparib formulations
MX2015013396A (es)	2016-07-08	Derivados de quinolinas como nuevos agentes contra el cancer.
HUE052332T2 (hu)	2021-04-28	Heteroaril-származék vagy gyógyászatilag elfogadható sója, eljárás annak elõállítására, és az ezeket hatóanyagént tartalmazó gyógyászati készítmény PI3 kinázokkal összefüggõ betegségek megelõzésére vagy kezelésére
EP4218823A3 (fr)	2023-11-15	Nouveaux promédicaments à base d'hormone de croissance humaine (hgh) polymère
HK1251481A1 (zh)	2019-02-01	使用白介素-17(il-17)拮抗剂治疗放射学阴性中轴型脊柱关节炎的方法
EA201691490A1 (ru)	2016-12-30	Фармацевтическая композиция, содержащая бринзоламид
EA201791537A1 (ru)	2018-01-31	Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение
EA201790949A1 (ru)	2018-02-28	Замещенные 2,4-диаминохинолины в качестве новых противораковых средств
EP3176163A4 (fr)	2018-01-10	Nouveau derive d'indene, son procede de preparation, et composition pharmaceutique pour la prevention ou le traitement de maladies retiniennes en contenant comme principe actif
EP3231436A4 (fr)	2018-07-25	Composition pharmaceutique pour la prévention ou le traitement d'une maladie métabolique, comprenant des bactéries bacteroides acidifaciens utilisées comme principe actif efficace
EA201691918A1 (ru)	2017-02-28	Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
IL261196A (en)	2018-10-31	A pharmaceutical preparation for cancer, containing a polyphenol compound as an active ingredient
EP3093023A4 (fr)	2017-10-11	Composition pharmaceutique pour le traitement du cancer et préparation pharmaceutique pour le traitement du cancer contenant ladite composition en tant que substance active
PT3604304T (pt)	2022-11-30	Composto derivado de pirrolo-piridina, método para a sua preparação e composição farmacêutica que o contém como substância ativa para prevenção ou tratamento de doenças relacionadas com proteína quinase
WO2018234871A3 (fr)	2019-04-25	Compositions pour administration de médicaments et leurs procédés d'utilisation
WO2015001541A3 (fr)	2015-11-26	Composition de film pharmaceutique
EA201792571A1 (ru)	2018-06-29	Терапевтическое применение l-4-хлорокинуренина
EA201792265A1 (ru)	2018-04-30	Способы лечения сердечно-сосудистых заболеваний
EA201991817A1 (ru)	2020-01-27	Интраназальная композиция, включающая бетагистин
PH12017550051A1 (en)	2018-01-29	A pharmaceutical composition for treating gastrointestinal diseases
WO2014125504A3 (fr)	2014-12-04	Compositions pharmaceutiques de fébuxostat